Fedha

Beta
Hisa unazofuatilia
Sekta za hisa
Alama
Alama
Bei
Tofauti
Tofauti ya asilimia
Mwenendo wa data
Bei ya Awali
Fungua
Juu
Chini
Kiasi cha mauzo ya hisa
Mtaji wa Soko
SIXB
Materials
SIXB
Materials
SIXB
+0.25%
1,104.10
+2.73
+0.25%
—1,101.371,103.631,105.311,091.41——
SIXC
Communications
SIXC
Communications
SIXC
-1.50%
604.16
-9.19
-1.50%
—613.35613.35613.35601.49——
SIXE
Energy
SIXE
Energy
SIXE
-0.09%
1,197.81
-1.02
-0.09%
—1,198.831,199.681,199.751,182.41——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,740.41
-15.54
-0.88%
—1,755.951,754.061,756.031,734.69——
SIXM
Financials
SIXM
Financials
SIXM
-0.64%
634.44
-4.07
-0.64%
—638.51637.41637.41633.05——
SIXR
Staples
SIXR
Staples
SIXR
-0.31%
840.90
-2.62
-0.31%
—843.52843.35846.40837.93——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.38%
215.13
-0.82
-0.38%
—215.95215.95216.84215.06——
SIXT
Technology
SIXT
Technology
SIXT
+2.86%
3,228.71
+89.80
+2.86%
—3,138.913,189.303,230.853,174.76——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.16%
935.87
+1.50
+0.16%
—934.37934.72938.26927.50——
SIXV
Health care
SIXV
Health care
SIXV
-1.37%
1,457.12
-20.31
-1.37%
—1,477.431,474.121,474.121,451.80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.83%
2,399.84
+19.65
+0.83%
—2,380.192,389.342,403.042,380.47——
GILD34:BVMF
Gilead Sciences Inc BDR
R$ 345.70
0.00%
(0.00) Siku 1
15 Apr, 13:25:50 GMT -3  ·   BRL
Alama zote
AlamaBeiTofautiTofauti ya asilimia
Inatayarisha maarifa maarufu ya GILD34...
Mtaji wa soko
161.86B
Wastani wa kiasi cha mauzo
10.00
Kiasi cha mauzo ya hisa
0.00
Juu kwa wiki 52
R$ 394.83
Chini kwa wiki 52
R$ 268.75
Hisa za wawekezaji
1.24B
Idadi ya wafanyakazi
elfu 17
Habari
Kutoka kwenye vyanzo vya wavuti
Wasifu
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir. It has recently expanded into different therapeutic areas such as oncology and inflammation. Gilead is a member of the Nasdaq-100 and the S&P 100. Gilead was founded in 1987 under the name Oligogen by Michael L. Riordan. The original name was a reference to oligonucleotides, small strands of DNA used to target genetic sequences. Gilead held its initial public offering in 1992, and successfully developed drugs like Tamiflu and Vistide that decade. In the 2000s, Gilead received approval for drugs including Viread and Hepsera, among others. It began evolving from a biotechnology company into a pharmaceutical company, acquiring several subsidiaries, though it still relied heavily on contracting to manufacture its drugs. The company continued its growth in the 2010s. Wikipedia
Kuhusu Gilead Sciences Inc BDR
Afisa Mkuu Mtendaji (CEO)Daniel O'Day
Wafanyakazielfu 17
Lilianzishwa22 Jun 1987
Makao makuuFoster City, California, Marekani
Sekta-
Tovutigilead.com
Simu inayofuata baada ya siku baada ya siku 12
Alhamisi, 7 Mei, 16:30
Kipindi cha Kifedha
Robo1 2026
Mapato Yaliyosawazishwa kwa Kila Hisa au Kadirio
-/ (1.91 inakadiriwa)USD
Mapato au Kadirio
-/ (6.92B inakadiriwa)USD
Mkutano pepe wa kujadili mapato ya robo ya Robo ya 1 ya mwaka wa fedha wa 2026
Inasubiri mkutano pepe wa kujadili mapato
Kwa muhtasari: mapato yajayoMaarifa kutoka kwenye ripoti na habari za hivi punde
Ripoti za awaliThamani zote katika USD
Loading Previous Earnings...
Taarifa ya mapato
Mapato
Mapato halisi
Thamani zote katika USD
Mac 2025
Jun 2025
Sep 2025
Des 2025
Mapato
6.67B
7.08B
7.77B
7.92B
Gharama ya bidhaa zilizouzwa
1.54B
1.50B
1.57B
1.62B
Gharama ya mapato
1.54B
1.50B
1.57B
1.62B
Gharama za utafiti na maendeleo
1.34B
1.45B
1.33B
1.57B
Jumla ya gharama za utafiti na maendeleo
-
-
-
-
Gharama za uuzaji, za jumla na za usimamizi
1.22B
1.36B
1.35B
1.78B
Gharama ya uendeshaji
2.56B
2.81B
2.69B
3.34B
Jumla ya gharama za uendeshaji
4.10B
4.31B
4.26B
4.96B
Mapato ya uendeshaji
2.57B
2.77B
3.51B
2.96B
Mapato mengine yasiyo ya uendeshaji
11.00M
13.00M
-23.00M
51.00M
EBT ikijumuisha vipengee visivyo vya kawaida
1.65B
2.43B
3.64B
2.08B
EBT bila kujumuisha vipengee visivyo vya kawaida
2.40B
2.58B
3.34B
2.80B
Gharama ya kodi ya mapato
334.00M
468.00M
589.00M
-105.00M
Kiwango cha kodi kinachotumika
20.25%
19.28%
16.18%
-5.05%
Gharama nyingine za uendeshaji
-
-
-
-
Mapato halisi
1.32B
1.96B
3.05B
2.18B
Kiwango cha faida halisi
19.72%
27.68%
39.28%
27.55%
Mapato kwa kila hisa
1.81
2.01
2.47
1.86
Mapato ya riba na uwekezaji
94.00M
73.00M
88.00M
95.00M
Gharama ya riba
-260.00M
-254.00M
-256.00M
-255.00M
Jumla ya gharama halisi za riba
-166.00M
-181.00M
-168.00M
-160.00M
Gharama za kushuka kwa thamani na za kulipa deni
-
-
-
-
Mapato ya kampuni kabla ya riba, kodi, kushuka thamani na kulipa madeni
3.26B
3.46B
4.20B
3.65B
Faida au hasara kutokana na uuzaji wa vipengee
-
-
-
-
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
UsaidiziTuma maoniFaraghaSheria na MashartiKanusho

Utafiti

Majukumu yangu
Bado hujaanzisha jukumu lolote
Majukumu yako yataonekana hapa. Ratibu majukumu na uruhusu Google Finance ifanye kazi ukiwa mbali.
Violezo
Muhtasari wa hisa unazofuatilia
Uchanganuzi wa kila siku wa kabla ya soko kufunguliwa wa orodha ya hisa unazofuatilia
Mapato Yajayo
Ripoti za mapato yajayo katika wiki
Mabadiliko ya Bei na Kiasi cha Hisa Kisicho cha Kawaida
Onyo la mapema kuhusu mabadiliko ya kiwango cha miamala leo
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
UsaidiziTuma maoniFaraghaSheria na MashartiKanusho